ASTRO Names Richard Hoppe President-Elect

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 12
Volume 4
Issue 12

MIAMI BEACH--Richard Hoppe, MD, has been named president-elect of the American Society for Therapeutic Radiology and Oncology (ASTRO). Dr. Hoppe is chairman of the Department of Radiation Oncology at Stanford University School of Medicine. He will take office at the Society's annual meeting to be held in Los Angeles next October.

MIAMI BEACH--Richard Hoppe, MD, has been named president-electof the American Society for Therapeutic Radiology and Oncology(ASTRO). Dr. Hoppe is chairman of the Department of RadiationOncology at Stanford University School of Medicine. He will takeoffice at the Society's annual meeting to be held in Los Angelesnext October.

The current president, who took office at this year's ASTRO meeting,is Steven A. Leibel, MD, vice-chairman, clinical director, andEnid A. Haupt Chair, Department of Radiation Oncology, MemorialSloan-Kettering Cancer Center.

Other new officers announced at the meeting are: chairman of theboard, Jay R. Harris, MD, Joint Center for Radiation Therapy,Harvard Medical School; secretary, Karen K. Fu, MD, Universityof California, San Francisco, Mt. Zion Cancer Center; and treasurer,John D. Earle, MD, Mayo Medical School.

Recent Videos
Once a patient-specific dose is determined, an all-oral combination of revumenib plus decitabine/cedazuridine and venetoclax may be “very good” in AML.
Patients with lung cancer who achieve a complete response with neoadjuvant therapy may not experience additional benefit with adjuvant immunotherapy.
Numerous trials have displayed the evolution of EGFR inhibition alone or with chemotherapy/radiation in the EGFR-mutated lung cancer space.
2 experts are featured in this series.
Although high grade adverse effects are infrequent among patients undergoing treatment for SCLC, CRS and ICANS may occur in higher frequencies.
Two experts are featured in this series.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Related Content